Pending EO 12866 Regulatory Review

RIN: 0938-ZC11	Received Date: 10/29/2026
Title: Medicare Drug Price Negotiation Program: Final Guidance, Manufacturer Effectuation of the Maximum Fair Price in 2028
Agency/Subagency: HHS / CMS	Stage: Notice
Legal Deadline: None	Economically Significant: No
International Impacts: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
Pandemic Response: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No